PrOton Pulsed reduCed dOse Rate Radiotherapy for Recurrent CNS maligNancies Trial

Abroad (travel likely)Recruiting

Conditions

Glioma · Glioma, Malignant · Recurrent Glioma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Lynn Cancer Institute at Baptist Health, Inc., Boca Raton, Florida, United States
Contact: Study coordinator (Hina Saeed, M.D.) · Hina.Saeed@baptisthealth.net · 561-374-5440
Miami Cancer Institute at Baptist Health, Inc., Miami, Florida, United States
Contact: Study coordinator (Robert Press, M.D.) · Robert.Press@baptisthealth.net · 786-596-2000
Contact: Study coordinator (Kristy Reyes) · Kristina.Reyes@baptisthealth.net · (786) 596-2000
Rupesh Kotecha, M.D. (Sub-investigator)
Contact: Principal Investigator (Robert Press, M.D.)

Study leads

Robert Press, M.D.
Principal Investigator
Miami Cancer Institute at Baptist Health, Inc.

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

Glioblastoma (GBM) · Newly Diagnosed Glioblastoma · GBM

Abroad (travel likely)RecruitingPHASE2

Springdale, United States · Los Angeles, United States

Medication Combinations of Dasatinib, Quercetin, Fisetin, Temozolomide, LMP744, and Autologous TLPO Vaccine for the Treatment of Previously Treated Glioma With Residual Disease

Glioma

Abroad (travel likely)RecruitingEARLY_PHASE1

Rochester, United States

Three miRNA Signatures in Glioma: From Molecular Mechanisms to Potential Clinical Application

Glioma

Abroad (travel likely)Recruiting

Rome, Italy

Symptom Cluster Heterogeneity and Gut Microbiota Mechanisms in Childhood Cancer Survivors

Cancer · Glioma · Leukemia (Both ALL and AML)

Abroad (travel likely)Recruiting

Hangzhou, China